https://www.selleckchem.com/products/mt-802.html
In addition, mutated cervical cancers display a higher tumor mutation burden (TM than non-mutated cancers. Frequent mutations of gene in squamous cervical carcinomas may represent an opportunity for targeted therapies development both inhibiting the PI3K kinase and associated pathway defects. Increased TMB may additionally confer immunotherapy sensitivity. Frequent mutations of PIK3CA gene in squamous cervical carcinomas may represent an opportunity for targeted therapies development both inhibiting the PI3K kinase and associated pathw
Like
Comment
Share
